About Werfen
Werfen is a company based in Barcelona (Spain) founded in 1959. The company has 346 employees as of December 31, 2022. Werfen has completed 5 acquisitions, including Accriva Diagnostics, Immucor and Instrumentation Laboratory.
- Headquarter Barcelona, Spain
- Employees 346 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$61.01 M (USD)6as on Dec 31, 2022
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
HSBC
& 4 more
-
Employee Count
346
as on Dec 31, 2022
-
Investments & Acquisitions
Accriva Diagnostics
& 4 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Werfen
Unlock access to complete
Unlock access to complete
Software Development Team
33 people
Leadership Team
27 people
Finance and Accounting
27 people
Sales and Marketing
15 people
Product Management Team
7 people
Operations Team
7 people
Senior Team
5 people
Manufacturing Team
5 people
Unlock access to complete
Funding Insights of Werfen
Investors in Werfen
Werfen has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include HSBC, Caixabank and BNP Paribas.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Universal banking and financial advisory services are provided globally.
|
Locked | Locked | Locked | |
|
Banking products and services are offered to individuals and businesses.
|
Locked | Locked | Locked | |
|
Banking and financial service provider
|
Locked | Locked | Locked |
Investor details for Werfen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Werfen
Werfen has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Accriva Diagnostics, Immucor and Instrumentation Laboratory.
Investment portfolio details for Werfen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Near-patient diagnostic systems for coagulation testing are developed.
|
Locked | Locked | 2009 | Locked | |
|
Disruptive innovations for targeted Next Generation Sequencing are commercialized.
|
Locked | Locked | 2009 | Locked | |
|
Transfusion and transplantation diagnostic products are provided by Immucor.
|
Locked | Locked | 1982 | Locked |
Complete acquisition details for Werfen
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Werfen
Detailed financials for Werfen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Werfen Comparisons
Peer comparison for Werfen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Werfen
Detailed competitors of Werfen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Werfen
Complete news archive for Werfen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Werfen
Werfen was founded in 1959 and raised its 1st funding round 56 years after it was founded.
Werfen is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
As of Dec 31, 2022, the latest employee count at Werfen is 346.
Annual revenue of Werfen is $61.01M as on Dec 31, 2022.
Werfen is engaged in the development, manufacture, and marketing of IVD testing solutions. The company offers a comprehensive product portfolio including instruments, software, reagents and service in the fields of Haemostasis, Critical Care and Autoimmunity diagnostics. In addition, the company distributes products in the area of Microbiology, Immunology, Blood bank, Molecular biology, Cytogenetics, and Urine analysis.
Werfen has made 5 acquisitions, including Accriva Diagnostics, Immucor, and Instrumentation Laboratory.
Werfen has 5 investors. Key investors include HSBC, Caixabank, BNP Paribas, BBVA, and European Union.